ISPAN PERFLUOROPROPANE (C3F8) GAS
Received Apr 14, 2026 · Event occurred Jul 5, 2022
Report 0002518435-2026-00008 · MDR key 24873503
Device
Generic name
Intraocular Gas
Manufacturer
Airgas Therapeutics LlcModel number
N/ACatalog number
8065797102
Product problems
- Adverse Event Without Identified Device or Use Problem
Patient
NA · Unknown
- Visual Impairment
Narrative
Description of Event or Problem
COMPLIANT ID: (B)(4). A CLINICAL STUDY (B)(6) REPORTED THAT AFTER A SURGERY A PATIENT EXPERIENCE POSTERIOR CAPSULAR OPACIFICATION (RIGHT EYE). SURGICAL DATE: (B)(6) 2022. EVENT START: JULY 26, 2022. EVENT END: JULY 26, 2022. MEASURES TAKEN: NON-MEDICATION TREATMENT. AE OUTCOME: RESOLVED. PHACOEMULSIFICATION AND INTRAOCULAR LENS IMPLANTATION + PARS PLANA VITRECTOMY + INTRAVITREAL INJECTION + RETINAL LASER PHOTOCOAGULATION + INTERNAL TAMPONADE FOR RETINAL DETACHMENT REPAIR (RIGHT EYE).
Additional Manufacturer Narrative
AN ANALYSIS OF THE RETAIN SAMPLE LOT 120716 SHOWED THAT THE PRODUCT WAS PFP AND MET ALL RELEASE CRITERIA. NOTHING WAS FOUND THAT WOULD ACCOUNT FOR THE REPORTED EVENT.